Harlan Waksal - Nov 10, 2023 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role: Executive Chair, Director
Signature: /s/ Ronan O'Brien, Attorney-in-Fact for Harlan Waksal, M.D.
Stock symbol: LYRA
Transactions as of: Nov 10, 2023
Transactions value $: $74,095
Form type: 4
Date filed: 11/13/2023, 05:29 PM
Previous filing: Feb 2, 2023
Next filing: Mar 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LYRA	Common Stock	Purchase	$74.1K	+25K	+10.55%	$2.96	262K	Nov 10, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at per share prices ranging from $2.83 to $3.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at per share prices ranging from $2.83 to $3.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Exhibit 24 - Power of Attorney.